News

Obesity at age 20 associated with increased risk of multiple sclerosis

View on the News

Causality not yet established

This study and other research linking obesity

early in life with the later development of MS are observational and cannot

establish causality, so we don’t yet know whether decreasing obesity with diet

and exercise will lead to a decrease in the incidence of MS.

Nevertheless, these findings are concerning. “It is

time to begin developing a targeted approach to prevent MS by improving common

health behaviors, including body weight and smoking,” Dr. Marrie and Dr. Beck

said.

People who are at high genetic risk can be readily

identified by focusing HLA genotyping on the first-degree relatives of known MS

patients, they added.

Dr. Marrie is in the departments of internal medicine and

community health sciences at the University of Manitoba, Winnipeg. She has

received funding from Sanofi-Aventis and Canadian governmental agencies and

nonprofit organizations, including the MS Society of Canada and the MS

Scientific Foundation. Dr. Beck is in the department of biostatistics and

computational biology at the University of Rochester (N.Y.) Medical Center. Dr.

Beck has received support from a variety of healthcare companies as well the

U.S. Food and Drug Administration and the U.S. National Institutes of Health.

These remarks were taken from their editorial accompanying Dr. Hedström’s report (Neurology 2014 [doi:10.1212/WNL.0000000000000195]).


 

FROM NEUROLOGY

Multiple sclerosis shows a "striking" association with obesity at age 20 years that strongly interacts with genetic susceptibility, according to an analysis of data from two case-control studies that examined environmental and genetic risk factors for MS.

This relationship between adolescent obesity and MS is of the same magnitude as the separate associations between MS and carriage of the high-risk HLA-DRB1*15 allele, absence of the protective HLA-A*02 allele, and smoking, said Dr. Anna Karin Hedström of the Institute of Environmental Medicine, Karolinska Institutet, Stockholm, and her associates.

"The biological explanations for these interactions are far from clear, but the data open [the way] for mechanistically oriented studies," they said.

Three previous studies have suggested that obesity in early life may be linked to increased risk of developing MS later. Dr. Hedström and her colleagues examined this association using data from a Swedish population-based, case-control study and from a separate American case-control study.

In the Swedish study, 1,510 adults with incident MS who were treated at 40 clinics across the country during a 7-year period and 2,017 control subjects completed detailed questionnaires concerning environmental exposures and other factors. The controls were matched for age, sex, and area of residence, and all the participants gave blood samples for HLA typing.

The American study involved 937 white adults with prevalent MS who were members of a single large health maintenance organization covering northern California and 609 white control subjects matched for age, sex, and area of residence. All the participants completed computer-assisted telephone interviews regarding environmental exposures and lifestyle factors.

All the subjects in both studies reported what their heights and weights had been at age 20 years, from which the investigators calculated body mass index (BMI).

In both studies, participants whose BMI at age 20 years was 27 kg/m2 or greater showed an increased risk of developing MS later in life, compared with those whose BMI was 18.5-21 kg/m2. The odds ratios (ORs) were 2.2 for subjects in the Swedish study and 1.8 for those in the American study, Dr. Hedström and her associates said (Neurology 2014 [doi:10.1212/WNL.0000000000000203]).

Similarly, participants with a slightly lower but still above-normal BMI of 25-27 kg/m2 showed a modestly increased risk of developing MS later in life: The ORs were 1.4 in the Swedish study and 1.3 in the American study.

These ORs were unchanged when a sensitivity analysis was performed, including only the study subjects who had been genotyped.

Participants who carried the high-risk HLA-DRB1*15 gene, did not carry the protective HLA-A*02 gene, and had a BMI of 27 kg/ m2 or greater at age 20 years had an OR of 16.2 for developing later MS, compared with those who had none of those risk factors. In contrast, subjects who had the same HLA profile but had not been obese at age 20 years had an OR of only 5.1.

The investigators proposed that the low-grade chronic inflammation associated with obesity, together with obesity’s adverse effects on autoimmunity, may raise the risk of HLA-related activation of T cells that attack the CNS.

Both the Swedish and the American study were limited in that they were retrospective and relied on participants’ self-reports. In addition, Dr. Hedström and her associates modified the usual definition of obesity for the purposes of their study. The typical standard for obesity is a BMI of greater than 30 kg/m2, not greater than 27 kg/m2. However, the number of subjects at this level of BMI was too small in the Swedish cohort to allow accurate analysis, so the researchers combined the top two categories of BMI into one designation of "obese."

This study was supported by several private nonprofit foundations, the Swedish Research Council for Health, Working Life and Welfare, and the U.S. National Institute of Neurological Disorders and Stroke. Dr. Hedström and five of the other seven authors reported no financial conflicts of interest. One coauthor reported ties to numerous industry sources and one reported receiving research support from Swedish government agencies.

Recommended Reading

Early anti-TNF-alpha treatment found effective in children with Crohn’s
MDedge Family Medicine
Predictions for 2014
MDedge Family Medicine
Treating pediatric bipolar disorder means leaning on adult data
MDedge Family Medicine
For successful inpatient video EEG monitoring, timing is everything
MDedge Family Medicine
Adding aripiprazole can reduce stubborn prolactin
MDedge Family Medicine
2014 childhood and adolescent immunization schedule now available
MDedge Family Medicine
Continuous glucose monitor approved for children down to age 2
MDedge Family Medicine
Transition to DSM-5 for Autism
MDedge Family Medicine
Preterm birth linked to hyperinsulinemia in childhood
MDedge Family Medicine
Video: Hospital births safer than home births
MDedge Family Medicine